9-Me-BC (9-methyl-b-carboline)(CAT: I021036) is a naturally occurring compound that belongs to the family of beta-carbolines. It has been found in various plants, fungi, and foods, and is known to have a variety of pharmacological properties. 9-Me-BC has been investigated for its potential as a treatment for neurological disorders, such as Alzheimer’s and Parkinson’s disease, due to its ability to inhibit monoamine oxidase (MAO), an enzyme that is involved in the breakdown of neurotransmitters such as dopamine and serotonin. By inhibiting MAO, 9-Me-BC can increase the levels of these neurotransmitters in the brain, which may have beneficial effects on cognitive function and motor control. In addition, 9-Me-BC has been found to have antioxidant and anti-inflammatory properties, which may contribute to its neuroprotective effects.
| Catalog Number | I021036 |
| CAS Number | 2521-07-5 |
| Synonyms | 9-Me-BC; 9-MeBC; 9-Me BC; 9Me-BC; 9 Me-BC; 9MeBC; 9 Me BC; 9-Methyl-BC; 9-Methyl-norharman; 9-Methyl-β-carboline; |
| Molecular Formula | C12H10N2 |
| Purity | 98 |
| Solubility | To be determined |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| IUPAC Name | 9-methyl-9H-pyrido[3,4-b]indole |
| InChI | InChI=1S/C12H10N2/c1-14-11-5-3-2-4-9(11)10-6-7-13-8-12(10)14/h2-8H,1H3 |
| InChIKey | MABOIYXDALNSES-UHFFFAOYSA-N |
| SMILES | CN1C2=C(C3=C1C=NC=C3)C=CC=C2 |
